Rosacea: turning all stones for source of pathology

Article

Usually diagnosed in people between the ages of 30 and 50, rosacea is a chronicsyndrome that affects 14 million Americans.

Related Videos
Related Content

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023

Make the Most of Your Visit to Asheville for Maui Derm NP + PA Fall 2023

September 27th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence

September 26th 2023

Analyzing the Safety of JAK Inhibitors in Atopic Dermatitis Treatment

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.